{"id":46058,"date":"2026-04-24T17:02:39","date_gmt":"2026-04-24T15:02:39","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=46058"},"modified":"2026-07-12T12:02:08","modified_gmt":"2026-07-12T10:02:08","slug":"nezadouci-ucinky-peptidu-medi-ghk-cu","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/cs\/skutki-uboczne-peptydu-miedzi-ghk-cu\/","title":{"rendered":"Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky m\u011bd\u011bn\u00e9ho peptidu (GHK-Cu) ve v\u011bdeck\u00fdch studi\u00edch"},"content":{"rendered":"

Zg\u0142aszane skutki uboczne peptidu m\u011bdi (GHK-Cu) ve v\u011bdeck\u00fdch studi\u00edch jsou obvykle minim\u00e1ln\u00ed a nej\u010dast\u011bji se omezuj\u00ed na m\u00edrn\u00e9 lok\u00e1ln\u00ed reakce. V klinick\u00fdch studi\u00edch na lidech, kde se pou\u017e\u00edvaly lok\u00e1ln\u00ed p\u0159\u00edpravky, nap\u0159\u00edklad v kontextu st\u00e1rnut\u00ed k\u016f\u017ee nebo hojen\u00ed ran, byl m\u011bd\u011bn\u00fd peptid obvykle dob\u0159e sn\u00e1\u0161en. N\u011bkte\u0159\u00ed \u00fa\u010dastn\u00edci hl\u00e1sili m\u00edrn\u00e9 podr\u00e1\u017ed\u011bn\u00ed poko\u017eky, lehk\u00e9 zarudnut\u00ed nebo p\u0159echodnou citlivost v m\u00edst\u011b aplikace (Pickart & Margolina, 2018; Reddy et al., 2012). Tyto p\u0159\u00edznaky jsou obvykle kr\u00e1tkodob\u00e9 a p\u0159i dal\u0161\u00edm pou\u017e\u00edv\u00e1n\u00ed nevydr\u017e\u00ed. Ve studi\u00edch na zv\u00ed\u0159atech a laboratorn\u00edch experimentech nebyly p\u0159i standardn\u00edch zku\u0161ebn\u00edch d\u00e1vk\u00e1ch pozorov\u00e1ny konzistentn\u00ed zn\u00e1mky syst\u00e9mov\u00e9 toxicity. Celkov\u011b je m\u011bd\u011bn\u00fd peptid \u010dasto popisov\u00e1n jako slou\u010denina s p\u0159\u00edzniv\u00fdm bezpe\u010dnostn\u00edm profilem ve srovn\u00e1n\u00ed s jin\u00fdmi biologicky aktivn\u00edmi peptidy.<\/p>\n

Z mechanistick\u00e9ho hlediska m\u016f\u017ee n\u00edzk\u00e1 frekvence ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f vypl\u00fdvat ze skute\u010dnosti, \u017ee tento peptid se p\u0159irozen\u011b vyskytuje v lidsk\u00e9m t\u011ble. Je p\u0159\u00edtomen v t\u011bln\u00edch tekutin\u00e1ch, jako je krevn\u00ed plazma a sliny, a v tk\u00e1n\u00edch, co\u017e sni\u017euje riziko imunitn\u00edch reakc\u00ed nebo toxicity. Krom\u011b toho m\u011bd\u011bn\u00fd peptid siln\u011b v\u00e1\u017ee m\u011b\u010f, co\u017e umo\u017e\u0148uje jej\u00ed kontrolovan\u00e9 dod\u00e1v\u00e1n\u00ed a omezuje hromad\u011bn\u00ed voln\u00e9 m\u011bdi, kter\u00e1 by mohla vyvolat oxida\u010dn\u00ed stres. Je v\u0161ak t\u0159eba zd\u016fraznit, \u017ee v\u011bt\u0161ina \u00fadaj\u016f o bezpe\u010dnosti poch\u00e1z\u00ed z lok\u00e1ln\u00edho pou\u017eit\u00ed, nikoli z celkov\u00e9 expozice. M\u011bd\u011bn\u00fd peptid pou\u017e\u00edvan\u00fd ve studi\u00edch je dostupn\u00fd od dodavatel\u016f, jako je SemaxPolska. Absence v\u00e1\u017en\u00fdch ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f v sou\u010dasn\u00fdch studi\u00edch neznamen\u00e1 potvrzenou dlouhodobou bezpe\u010dnost, zejm\u00e9na p\u0159i vy\u0161\u0161\u00edch d\u00e1vk\u00e1ch nebo celkov\u00e9m pod\u00e1n\u00ed.<\/p>\n

Je peptid m\u011bdi (GHK-Cu) pova\u017eov\u00e1n za bezpe\u010dn\u00fd v klinick\u00e9m v\u00fdzkumu u lid\u00ed?<\/strong><\/h2>\n

Peptid m\u011bdi je na z\u00e1klad\u011b dostupn\u00fdch klinick\u00fdch a kosmetick\u00fdch studi\u00ed obecn\u011b pova\u017eov\u00e1n za bezpe\u010dn\u00fd, zejm\u00e9na p\u0159i lok\u00e1ln\u00ed aplikaci. Je v\u0161ak t\u0159eba poznamenat, \u017ee komplexn\u00ed \u00fadaje o bezpe\u010dnosti pro r\u016fzn\u00e9 zp\u016fsoby pod\u00e1n\u00ed jsou st\u00e1le omezen\u00e9. Kontrolovan\u00e9 studie na lidech, v\u010detn\u011b studi\u00ed t\u00fdkaj\u00edc\u00edch se st\u00e1rnut\u00ed k\u016f\u017ee a hojen\u00ed ran, nazna\u010duj\u00ed dobrou sn\u00e1\u0161enlivost a \u017e\u00e1dn\u00e9 z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky. Tyto studie, zahrnuj\u00edc\u00ed pravideln\u00e9 pou\u017e\u00edv\u00e1n\u00ed po dobu n\u011bkolika t\u00fddn\u016f, sou\u010dasn\u011b ukazuj\u00ed zlep\u0161en\u00ed parametr\u016f k\u016f\u017ee (Pickart & Margolina, 2018; Mulder et al., 1994), co\u017e nazna\u010duje p\u0159ijatelnou kr\u00e1tkodobou bezpe\u010dnost pro dermatologick\u00e9 aplikace.<\/p>\n

V\u011bt\u0161ina dat v\u0161ak poch\u00e1z\u00ed z kosmetick\u00fdch nebo lok\u00e1ln\u00edch aplikac\u00ed. Chyb\u00ed velk\u00e9, dob\u0159e navr\u017een\u00e9 klinick\u00e9 studie hodnot\u00edc\u00ed dlouhodob\u00e9 u\u017e\u00edv\u00e1n\u00ed, syst\u00e9mov\u00e9 pod\u00e1v\u00e1n\u00ed nebo \u00fa\u010dinky v r\u016fzn\u00fdch populac\u00edch. V n\u011bkter\u00fdch zem\u00edch je m\u011b\u010fnat\u00fd peptid klasifikov\u00e1n jako kosmetick\u00e1 slo\u017eka, nikoli l\u00e9\u010div\u00fd p\u0159\u00edpravek, co\u017e odr\u00e1\u017e\u00ed sou\u010dasnou \u00farove\u0148 v\u011bdeck\u00fdch d\u016fkaz\u016f.<\/p>\n

Z biologick\u00e9ho hlediska jeho p\u0159irozen\u00e1 p\u0159\u00edtomnost v t\u011ble a pod\u00edl na regenera\u010dn\u00edch procesech podporuj\u00ed jeho bezpe\u010dnostn\u00ed profil. To v\u0161ak nenahrazuje pot\u0159ebu dal\u0161\u00edho klinick\u00e9ho v\u00fdzkumu. Peptid m\u011bdi pou\u017e\u00edvan\u00fd ve studi\u00edch je dostupn\u00fd prost\u0159ednictv\u00edm dodavatel\u016f, jako je SemaxPolska. Sou\u010dasn\u00e1 data nazna\u010duj\u00ed bezpe\u010dnost p\u0159i lok\u00e1ln\u00edm pou\u017eit\u00ed, ale nepotvrzuj\u00ed plnou klinickou bezpe\u010dnost p\u0159i dlouhodob\u00e9m nebo syst\u00e9mov\u00e9m pod\u00e1v\u00e1n\u00ed.<\/p>\n

Jakie dane toksykologiczne dotycz\u0105 peptidu m\u011bdi (GHK-Cu) v odborn\u00e9 literatu\u0159e?<\/strong><\/h2>\n

Toksikologick\u00e9 \u00fadaje t\u00fdkaj\u00edc\u00ed se m\u011bd\u011bn\u00e9ho peptidu nazna\u010duj\u00ed n\u00edzkou toxicitu jak v laboratorn\u00edch (in vitro), tak na zv\u00ed\u0159ec\u00edch (in vivo) studi\u00edch. Studie ukazuj\u00ed, \u017ee m\u011bd\u011bn\u00fd peptid nem\u00e1 negativn\u00ed vliv na \u017eivotaschopnost bun\u011bk v koncentrac\u00edch bl\u00edzk\u00fdch t\u011bm, kter\u00e9 se vyskytuj\u00ed v biologick\u00fdch syst\u00e9mech. N\u011bkter\u00e9 studie dokonce prok\u00e1zaly, \u017ee podporuje regeneraci bun\u011bk a zvy\u0161uje antioxida\u010dn\u00ed aktivitu (Gruchlik et al., 2012). Studie na zv\u00ed\u0159atech, zam\u011b\u0159en\u00e9 na hojen\u00ed ran, z\u00e1n\u011bty a regeneraci tk\u00e1n\u00ed, neodhalily po\u0161kozen\u00ed org\u00e1n\u016f ani v\u00fdznamn\u00e9 syst\u00e9mov\u00e9 \u00fa\u010dinky p\u0159i typick\u00fdch testovac\u00edch d\u00e1vk\u00e1ch (Ma et al., 2020; Park et al., 2016).<\/p>\n

Dodatkov\u00e9 studie t\u00fdkaj\u00edc\u00ed se bezpe\u010dnosti k\u016f\u017ee poukazuj\u00ed na n\u00edzk\u00fd dr\u00e1\u017ediv\u00fd potenci\u00e1l, a to i p\u0159i opakovan\u00e9m lok\u00e1ln\u00edm pou\u017eit\u00ed (Lima & Moraes, 2018). D\u016fle\u017eit\u00fdm faktorem je tak\u00e9 rychl\u00fd metabolismus a vylu\u010dov\u00e1n\u00ed z organismu, co\u017e sni\u017euje riziko kumulace.<\/p>\n

Z mechanistick\u00e9ho hlediska p\u016fsob\u00ed m\u011bd\u011bn\u00fd peptid jako regul\u00e1tor biologick\u00fdch proces\u016f, ovliv\u0148uje genovou expresi a oxida\u010dn\u00ed rovnov\u00e1hu, m\u00edsto aby vyvol\u00e1val silnou biologickou odpov\u011b\u010f p\u0159i vysok\u00fdch koncentrac\u00edch, jak je tomu u n\u011bkter\u00fdch l\u00e1tek. To p\u0159isp\u00edv\u00e1 k jeho n\u00edzk\u00e9 toxicit\u011b. Je v\u0161ak t\u0159eba zd\u016fraznit, \u017ee v\u011bt\u0161ina toxikologick\u00fdch \u00fadaj\u016f poch\u00e1z\u00ed z preklinick\u00fdch a kr\u00e1tkodob\u00fdch studi\u00ed. M\u011bd\u011bn\u00fd peptid pou\u017e\u00edvan\u00fd ve v\u00fdzkumu je dostupn\u00fd prost\u0159ednictv\u00edm dodavatel\u016f, jako je SemaxPolska. Sou\u010dasn\u00e9 \u00fadaje nejsou dostate\u010dn\u00e9 k ur\u010den\u00ed bezpe\u010dn\u00fdch \u00farovn\u00ed expozice pro v\u0161echny metody aplikace ani pro dlouhodob\u00e9 u\u017e\u00edv\u00e1n\u00ed u lid\u00ed.<\/p>\n

Byly v p\u0159\u00edpadov\u00fdch studi\u00edch hl\u00e1\u0161eny probl\u00e9my s rovnov\u00e1hou m\u011bdi?<\/strong><\/h2>\n

Potenci\u00e1ln\u00ed rizika spojen\u00e1 s nerovnov\u00e1hou m\u011bdi byla v studi\u00edch zva\u017eov\u00e1na, av\u0161ak nejev\u00ed siln\u00e9 potvrzen\u00ed v experiment\u00e1ln\u00edch v\u00fdsledc\u00edch p\u0159i standardn\u00edch hladin\u00e1ch pou\u017e\u00edvan\u00fdch ve v\u00fdzkumu. Peptid m\u011bdi (GHK-Cu) siln\u011b v\u00e1\u017ee m\u011b\u010f a p\u016fsob\u00ed jako \u0159\u00edzen\u00fd nosi\u010d, co\u017e znamen\u00e1, \u017ee ji transportuje v bezpe\u010dn\u00e9 form\u011b m\u00edsto zvy\u0161ov\u00e1n\u00ed hladiny voln\u00fdch iont\u016f m\u011bdi. Voln\u00e1 m\u011b\u010f m\u016f\u017ee iniciovat \u0161kodliv\u00e9 oxida\u010dn\u00ed reakce, zat\u00edmco peptid m\u011bdi omezuje toto riziko t\u00edm, \u017ee udr\u017euje m\u011b\u010f ve stabiln\u00edm a regulovan\u00e9m stavu (Pickart et al., 2015).<\/p>\n

V\u00fdzkumy oxida\u010dn\u00edho stresu nazna\u010duj\u00ed, \u017ee m\u011bd\u011bn\u00fd peptid m\u016f\u017ee dokonce sni\u017eovat po\u0161kozen\u00ed bun\u011bk podporou antioxida\u010dn\u00edch syst\u00e9m\u016f a regulac\u00ed gen\u016f souvisej\u00edc\u00edch s ochranou p\u0159ed oxida\u010dn\u00edm stresem (Ma et al., 2020). Existuj\u00ed v\u0161ak teoretick\u00e9 obavy, \u017ee velmi vysok\u00e9 d\u00e1vky nebo neobvykl\u00e1 kumulace by mohly ovlivnit p\u0159irozenou rovnov\u00e1hu m\u011bdi v t\u011ble, zejm\u00e9na v syst\u00e9mech citliv\u00fdch na hladinu kov\u016f.<\/p>\n

Dosavadn\u00ed v\u00fdzkum neprok\u00e1zal jednozna\u010dn\u00e9 p\u0159\u00edpady nadbytku m\u011bdi ani v\u00fdznamn\u00e9 nerovnov\u00e1hy spojen\u00e9 s pou\u017eit\u00edm m\u011bd\u011bn\u00e9ho peptidu za standardn\u00edch experiment\u00e1ln\u00edch nebo kosmetick\u00fdch podm\u00ednek. Je v\u0161ak t\u0159eba m\u00edt na pam\u011bti, \u017ee v\u011bt\u0161ina studi\u00ed je prov\u00e1d\u011bna v kontrolovan\u00fdch podm\u00ednk\u00e1ch, p\u0159i relativn\u011b n\u00edzk\u00fdch d\u00e1vk\u00e1ch a lok\u00e1ln\u00edm pod\u00e1n\u00ed, co\u017e omezuje mo\u017enost zobecn\u011bn\u00ed v\u00fdsledk\u016f.<\/p>\n

Z mechanistick\u00e9ho hlediska pom\u00e1h\u00e1 m\u011bd\u011bn\u00fd peptid udr\u017eovat rovnov\u00e1hu m\u011bdi t\u00edm, \u017ee funguje jako \u0159\u00edzen\u00fd transportn\u00ed syst\u00e9m. Tato rovnov\u00e1ha v\u0161ak z\u00e1vis\u00ed na faktorech, jako je d\u00e1vka, zp\u016fsob pod\u00e1n\u00ed a biologick\u00fd kontext. Peptid m\u011bdi pou\u017e\u00edvan\u00fd ve v\u00fdzkumu je k dispozici prost\u0159ednictv\u00edm dodavatel\u016f, jako je SemaxPolska. Navzdory nedostatku jasn\u00fdch d\u016fkaz\u016f o riziku dysbalance m\u011bdi nen\u00ed vliv dlouhodob\u00e9ho nebo vysokod\u00e1vkovan\u00e9ho syst\u00e9mov\u00e9ho pod\u00e1v\u00e1n\u00ed pln\u011b pochopen a vy\u017eaduje dal\u0161\u00ed v\u00fdzkum.<\/p>\n

 <\/p>\n

Odkazy<\/h4>\n
    \n
  • Pickart, L., & Margolina, A. (2018). Regenerativn\u00ed a ochrann\u00e9 \u00fa\u010dinky peptidu GHK-Cu ve sv\u011btle nov\u00fdch genov\u00fdch dat. International Journal of Molecular Sciences, 19<\/em>(7), 1987.<\/span><\/li>\n
  • Reddy, B. Y., Jow, T., & Hantash, B. M. (2012). Bioaktivn\u00ed oligopeptidy v dermatologii: \u010c\u00e1st I. Experiment\u00e1ln\u00ed dermatologie, 21<\/em>(8), 563\u2013568.<\/span><\/li>\n
  • Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Zlep\u0161en\u00ed hojen\u00ed v\u0159ed\u016f u pacient\u016f s diabetem pomoc\u00ed topick\u00e9 l\u00e9\u010dby m\u011bd\u00ed glycyl-L-histidyl-L-lysinem. Oprava a regenerace ran, 2<\/em>(4), 259\u2013269.<\/span><\/li>\n
  • Gruchlik, A., Jurzak, M., Chodurek, E., & Dzierzewicz, Z. (2012). Vliv Gly-Gly-His, Gly-His-Lys a jejich m\u011b\u010fnat\u00fdch komplex\u016f na sekreci IL-6 z\u00e1vislou na TNF-\u03b1 u norm\u00e1ln\u00edch lidsk\u00fdch derm\u00e1ln\u00edch fibroblast\u016f. Acta Poloniae Pharmaceutica, 69<\/em>(6), 1303\u20131309.<\/span><\/li>\n
  • Ma, W., Li, M., Ma, H., Li, W., Liu, L., Yin, Y., Zhou, X., & Hou, G. (2020). Ochrann\u00e9 \u00fa\u010dinky GHK-Cu p\u0159i plicn\u00ed fibr\u00f3ze indukovan\u00e9 bleomycinem prost\u0159ednictv\u00edm antioxida\u010dn\u00edho stresu a protiz\u00e1n\u011btliv\u00fdch drah. P\u0159\u00edrodn\u00ed v\u011bdy, 241<\/em>, 117139.<\/span><\/li>\n
  • Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). Tripeptidov\u00fd komplex GHK-Cu zm\u00edr\u0148uje akutn\u00ed po\u0161kozen\u00ed plic vyvolan\u00e9 lipopolysacharidem u my\u0161\u00ed. Oncotarget, 7<\/em>(37), 58405\u201358417.<\/span><\/li>\n
  • Lima, T. N., & Pedriali Moraes, C. A. (2018). Bioaktivn\u00ed peptidy: Aplikace a v\u00fdznam pro kosmeceutika. Kosmetika, 5<\/em>(2), 21.<\/span><\/li>\n
  • Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK-Cu m\u016f\u017ee chr\u00e1nit poko\u017eku p\u0159ed oxida\u010dn\u00edm stresem regulac\u00ed m\u011bdi a ovlivn\u011bn\u00edm exprese \u010detn\u00fdch antioxida\u010dn\u00edch gen\u016f. Kosmetika, 2<\/em>(3), 236\u2013247.<\/span><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"

    Hl\u00e1\u0161en\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky m\u011b\u010fnat\u00e9ho peptidu (GHK-Cu) v\u011bdeck\u00fdch studi\u00edch jsou obvykle minim\u00e1ln\u00ed a nej\u010dast\u011bji se omezuj\u00ed na m\u00edrn\u00e9 lok\u00e1ln\u00ed reakce. V lidsk\u00fdch studi\u00edch se v\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-46058","post","type-post","status-publish","format-standard","hentry","category-kategoria-ghk-cu","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/46058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/comments?post=46058"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/46058\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/media?parent=46058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/categories?post=46058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/tags?post=46058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}